Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
associated decrease » associated increase (Expand Search), associated disease (Expand Search), associated diseases (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
associated decrease » associated increase (Expand Search), associated disease (Expand Search), associated diseases (Expand Search)
-
1001
-
1002
Line graph showing the values of inflammatory cytokines at baseline and after treatment.
Published 2025Subjects: -
1003
Baseline descriptive characteristics of trial participants (n = 140) with and without dizziness.
Published 2024Subjects: -
1004
-
1005
-
1006
-
1007
Frequency distribution of SOLEC at baseline and follow-ups in the NSEIT and NSE groups.
Published 2024Subjects: -
1008
-
1009
Baseline and Post-Treatment Results of Echocardiographic Variables in Each Experimental Group.
Published 2025Subjects: -
1010
-
1011
-
1012
Baseline descriptive characteristics of trial participants with dizziness, by treatment group.
Published 2024Subjects: -
1013
-
1014
Baseline and Post-Treatment Serum Cytokine Levels in Each Investigational Group.
Published 2025Subjects: -
1015
-
1016
Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group.
Published 2025Subjects: -
1017
Variables obtained from the SF-36 quality of life questionnaire in each experimental group.
Published 2025Subjects: -
1018
-
1019
-
1020